glucose, (beta-d)-isomer has been researched along with Atrial Remodeling in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, M; Lee, S; Li, G; Liu, T; Meng, L; Shao, Q; Tse, G; Zhang, Z; Zhao, J; Zhao, Y | 1 |
| de Boer, RA; Rienstra, M; Silljé, HHW; Westenbrink, BD; Yurista, SR | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Atrial Remodeling
| Article | Year |
|---|---|
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.
Topics: Animals; Atrial Fibrillation; Atrial Function, Left; Atrial Remodeling; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Glucosides; Heart Rate; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Proteins; Organelle Biogenesis; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2019 |
Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Glucosides; Humans; Mitochondria; Rats; Sodium; Sodium-Glucose Transporter 2; Streptozocin | 2020 |